LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme

Glioblastoma multiforme (GBM) and primary central nervous system lymphoma (PCNSL) are both malignant cerebral tumors; however, their treatments are vastly different. Early and precise diagnosis is vital for subsequent adequate treatment to improve prognosis. Reliable biomarkers that can easily disti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Le, Xu, Lixia, Lu, Shan, Yan, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193164/
https://www.ncbi.nlm.nih.gov/pubmed/32237064
http://dx.doi.org/10.1002/2211-5463.12849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193164/
https://www.ncbi.nlm.nih.gov/pubmed/32237064
http://dx.doi.org/10.1002/2211-5463.12849

Ejemplares similares